Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer

The triple-negative breast cancer (TNBC) is a very aggressive tumor type often occurring in young women and is associated with a bad prognosis for the patients. TNBC lacks established targets for breast cancer therapy, such as the estrogen receptor (ER), progesterone receptor (PR) and the human epid...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Huber, Michaela C., Falkenberg, Natalie, Hauck, Stefanie M., Priller, Markus, Braselmann, Herbert, Feuchtinger, Annette, Walch, Axel, Schmitt, Manfred, Aubele, Michaela
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2016
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5190079/
https://ncbi.nlm.nih.gov/pubmed/27286449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9853
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items